e-learning
resources
ERJ
2004
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
BMPR2 mutations in pulmonary arterial hypertension with congenital heart disease
Roberts K.E., McElroy J.J., Wong W.P.K., Yen E., Widlitz A., Barst R.J., Knowles J.A., Morse J.H.
Source:
Eur Respir J 2004; 24: 371-374
Journal Issue:
September
Disease area:
Pulmonary vascular diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
Roberts K.E., McElroy J.J., Wong W.P.K., Yen E., Widlitz A., Barst R.J., Knowles J.A., Morse J.H.. BMPR2 mutations in pulmonary arterial hypertension with congenital heart disease. Eur Respir J 2004; 24: 371-374
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Observational cohort study of pulmonary exacerbations in alpha-1 antitrypsin deficiency
The definition of pulmonary hypertension: history, practical implications and current controversies
Asbestosis
Related content which might interest you:
Pulmonary arterial hypertension associated with congenital heart disease
Source: Eur Respir Rev 2012 21: 328-337
Year: 2012
Pulmonary arterial hypertension in paediatric and adult patients with congenital heart disease
Source: Eur Respir Rev 2009; 18: 154-161
Year: 2009
Genetics of pulmonary hypertension: from bench to bedside
Source: Eur Respir J 2002; 20: 741-749
Year: 2002
Managing pulmonary hypertension in patients with congenital heart disease
Source: Eur Respir Mon 2012; 57: 71-81
Year: 2012
Therapeutic approaches in adults with congenital heart disease-associated pulmonary arterial hypertension
Source: Eur Respir Rev 2010 19: 300-307
Year: 2010
Changing demographics of pulmonary arterial hypertension in congenital heart disease
Source: Eur Respir Rev 2010 19: 308-313
Year: 2010
Double combination therapy in patients with pulmonary arterial hypertension associated with congenital heart defects
Source: Annual Congress 2011 - Treatment of human pulmonary hypertension
Year: 2011
Pulmonary hypertension in children
Source: Eur Respir Mon 2012; 57: 94-107
Year: 2012
TBX4 syndrome: a systemic disease highlighted by pulmonary arterial hypertension in its most severe form
Source: Eur Respir J, 55 (5) 2000585; 10.1183/13993003.00585-2020
Year: 2020
Clinical characteristics, hemodynamics and survival in idiopathic and familial pulmonary arterial hypertension with germline BMPR2 mutation
Source: Eur Respir J 2007; 30: Suppl. 51, 250s
Year: 2007
Effect of sitaxentan in patients with pulmonary arterial hypertension associated to congenital heart diseases
Source: Annual Congress 2009 - Pulmonary vascular diseases
Year: 2009
BMPR2 germline mutations in pulmonary hypertension associated with fenfluramine derivatives
Source: Eur Respir J 2002; 20: 518-523
Year: 2002
T-box protein 4
mutation causing pulmonary arterial hypertension and lung disease
Source: Eur Respir J, 54 (2) 1900388; 10.1183/13993003.00388-2019
Year: 2019
Pulmonary arterial hypertension preceding idiopathic pulmonary fibrosis in a BMPR2 mutation positive patient
Source: Eur Respir Rev 2014; 23: 147-149
Year: 2014
Adult congenital heart disease and pulmonary hypertension: management of a complex case
Source: Eur Respir Rev 2012 21: 362-364
Year: 2012
Severe pulmonary hypertension after the discovery of the familial primary pulmonary hypertension gene
Source: Eur Respir J 2001; 17: 1065-1069
Year: 2001
Pre-implantation genetic diagnosis in pulmonary arterial hypertension due to BMPR2 mutation
Source: Eur Respir J 2012; 39: 1534-1535
Year: 2012
Endoglin germline mutation, hereditary hemorrhagic telangiectasia and fenfluramine-associated pulmonary arterial hypertension
Source: Eur Respir J 2003; 22: Suppl. 45, 463s
Year: 2003
Pulmonary arterial hypertension associated with fenfluramine exposure: report of 109 cases
Source: Eur Respir J 2008; 31: 343-348
Year: 2008
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept